-
30/06/2025
MDCG 2025-4: Key Guidance for Medical Device Software on Online Platforms
Published in June 2025, this document clarifies the regulatory obligations for all parties involved in bringing Medical Device Software (MDSW) apps to the EU market, with a particular emphasis on online platform providers.
-Read more-
-
30/06/2025
Meet the new chair of the Young Scientists Committee: Dr Shiny Martis
We’re excited to introduce Shiny Martis, the newly appointed Chair of the VPHi Young Scientists Committee (YSC)!
-Read more-
-
27/06/2025
News from the Medical Device Coordination Group
On 19 June 2025 the MDCG released a comprehensive FAQ on the interplay between the Medical Devices Regulation & In vitro Diagnostic Medical Devices Regulation and the Artificial Intelligence Act
-Read more-
-
27/06/2025
SimCardioTest concludes its activities with an engaging final event in Barcelona
VPH showcases the value, impact and outcomes of stakeholder engagement, within Horizon project – SimCardioTest, a consortium of hearts.
-Read more-
-
25/06/2025
In the literature: June 2025 highlights
Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter!
-Read more-
-
25/06/2025
Commission seeks experts for AI Scientific Panel
The European Commission is setting up a scientific panel of independent experts to support the implementation and enforcement of the AI Act.
-Read more-
-
25/06/2025
The European Virtual Human Twins (VHT) Initiative is entering its the next phase
The European Commission is organising a high-level event to discuss the strategic vision for the European Virtual Human Twins Initiative – a major step towards driving AI innovation and making personalised medicine a reality.
-Read more-
-
17/06/2025
When the world fell silent: The role of in silico medicine during the COVID-19 crisis. Part 2/3
In this second article of our series on in silico medicine during the COVID-19 response, we explore how computer models helped optimise vaccine doses, test therapies, as well as simulate immune responses, virtually—saving time, reducing risk, and guiding smarter, faster decisions in a race against the clock.
-Read more-